Abstract:Alzheimer's disease (AD) is a neurodegenerative disorder associated with age. A wealth of evidence indicates that the amyloid β (Aβ) aggregates result from dyshomeostasis between Aβ production and clearance, which plays a pivotal role in the pathogenesis of AD. Consequently, therapies targeting Aβ reduction represent a promising strategy for AD intervention. Tetramethylpyrazine nitrone (TBN) is a novel tetramethylpyrazine derivative with potential for the treatment of AD. Previously, we demonstrated that TBN markedly enhanced cognitive functions and decreased the levels of Aβ, APP, BACE 1, and hyperphosphorylated tau in 3×Tg-AD mice. However, the mechanism by which TBN inhibits Aβ deposition is still unclear. In this study, we employed APP/PS1 mice treated with TBN (60 mg/kg, ig, bid) for six months, and N2a/APP695swe cells treated with TBN (300 μM) to explore the mechanism of TBN in Aβ reduction. Our results indicate that TBN significantly alleviated cognitive impairment and reduced Aβ deposition in APP/PS1 mice. Further investigation of the underlying mechanisms revealed that TBN decreased the expression of APP and BACE1, activated the AMPK/mTOR/ULK1 autophagy pathway, inhibited the PI3K/AKT/mTOR/ULK1 autophagy pathway, and decreased the phosphorylation levels of JNK and ERK in APP/PS1 mice. Moreover, TBN was found to significantly reduce the mRNA levels of APP and BACE1, as well as those of SP1, CTCF, TGF-β, and NF-κB, transcription factors involved in regulating gene expression. Additionally, TBN was observed to decrease the level of miR-346 and increase the levels of miR-147 and miR-106a in the N2a/APP695swe cells. These findings indicate that TBN may reduce Aβ levels likely by reducing APP expression by regulating APP gene transcriptional factors and miRNAs, reducing BACE1 expression, and promoting autophagy activities.

Catalpol Inhibits Amyloid-β Generation Through Promoting Α-Cleavage of APP in Swedish Mutant APP Overexpressed N2a Cells

Catalpol rescues cognitive deficits by attenuating amyloid β plaques and neuroinflammation

Catalpol Attenuates the Neurotoxicity Induced by Β-Amyloid1–42 in Cortical Neuron–glia Cultures

Catalpol Mitigates Alzheimer's Disease Progression by Promoting the Expression of Neural Stem Cell Exosomes Released miR-138-5p

Effects of Catalpol on Alzheimer's Disease and Its Mechanisms

Inhibition of Γ-Secretase Activity Reduces Aβ Production, Reduces Oxidative Stress, Increases Mitochondrial Activity and Leads to Reduced Vulnerability to Apoptosis: Implications for the Treatment of Alzheimer's Disease

Effect of Catalpol from Radix Rehmanniae on Aβ_(25-35)-induced Apoptosis of PC12 Cells

Neuroprotective activities of catalpol against CaMKII-dependent apoptosis induced by LPS in PC12 cells.

Crocin Inhibited Amyloid-Beta (aβ) Generation Via Promoting Non-Amyloidogenic APP Processing and Suppressed ER Stress UPR Signaling in N2a/APP Cells

Decrease in the Generation of Amyloid-β Due to Salvianolic Acid B by Modulating BACE1 Activity

Dieckol Ameliorates Aβ Production via PI3K/Akt/GSK-3β Regulated APP Processing in SweAPP N2a Cell

New Protein Kinase C Activator Regulates Amyloid Precursor Protein Processing In Vitro By Increasing Alpha-Secretase Activity

New protein kinase C activator regulates amyloid precursor protein processing in vitro by increasing α-secretase activity: New PKC activator increases α-secretase activity

Autophagy Activation by Terminalia Chebula Retz. Reduce Aβ Generation by Shifting APP Processing Toward Non-Amyloidogenic Pathway in APPswe Transgenic SH-SY5Y Cells.

Cathepsin B Degrades Amyloid-β in Mice Expressing Wild-type Human Amyloid Precursor Protein

P4‐687: SUBSTRATE BINDING INHIBITS Γ‐secretase CLEAVAGE OF AMYLOID PRECURSOR PROTEIN

Berberine modulates amyloid-β peptide generation by activating AMP-activated protein kinase.

Tetramethylpyrazine Nitrone (TBN) Reduces Amyloid β Deposition in Alzheimer's Disease Models by Modulating APP Expression, BACE1 Activity, and Autophagy Pathways

Curcumin Mediates Presenilin-1 Activity to Reduce Β-Amyloid Production in a Model of Alzheimer’s Disease

The Regulation of Curcumin on the Amyloidogentic Pathaway of APP in Alzheimers Disease

Catalpol Exerts a Neuroprotective Effect in the MPTP Mouse Model of Parkinson’s Disease